News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Boothe Douglas
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/10/2020 |
4
| Boothe Douglas (President and CEO) has filed a Form 4 on AKORN INC|
Txns:
| Paid exercise price by delivering 41,353 shares
@ $1.25, valued at
$51.7k
|
|
| 01/08/2019 |
4
| Boothe Douglas (President and CEO) has filed a Form 4 on AKORN INC|
Txns:
| Granted 507,614 shares
@ $0
Granted 405,938 options to buy
@ $3.94, valued at
$1.6M
Granted 253,807 options to buy
@ $0 |
|
| 01/08/2019 |
3
| Boothe Douglas (President and CEO) has filed a Form 3 on AKORN INC |
| 05/08/2018 |
4
| Boothe Douglas (President, Generics Division) has filed a Form 4 on Impax Laboratories, LLC|
Txns:
| Disposed/sold 14,145 shares
@ $0
Disposed/sold 41,756 shares
@ $0
Disposed/sold 50,500 options to buy
@ $24.42, valued at
$1.2M
Disposed/sold 56,232 options to buy
@ $9.35, valued at
$525.8k
|
|
| 03/05/2018 |
4
| Boothe Douglas (President, Generics Division) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Paid exercise price by delivering 2,041 shares
@ $19.5, valued at
$39.8k
|
|
| 08/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/31/2016 |
4
| Boothe Douglas (President, Generics Division) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Granted 62,600 shares
@ $0
Granted 50,500 options to buy
@ $24.42, valued at
$1.2M
|
|
| 08/02/2016 |
3
| Boothe Douglas (President, Generics Division) has filed a Form 3 on IMPAX LABORATORIES INC |
| 03/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/25/2015 |
4
| Boothe Douglas (EVP & GM Perrigo Pharma) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Granted 885 shares
@ $186.89, valued at
$165.4k
Paid exercise price by delivering 330 shares
@ $186.89, valued at
$61.7k
Exercised 395 shares
@ $186.89, valued at
$73.8k
Paid exercise price by delivering 148 shares
@ $186.89, valued at
$27.7k
Exercised 395 restricted stock units
@ $0 |
|
| 07/01/2015 |
4
| Boothe Douglas (EVP & GM Perrigo Pharma) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Granted 2,285 restricted stock units
@ $0 |
|
| 08/25/2014 |
4
| Boothe Douglas (EVP & GM Perrigo Pharma) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Granted 1,113 restricted stock units
@ $0
Granted 6,029 options to buy
@ $147.75, valued at
$890.8k
Granted 338 restricted stock units
@ $0 |
|
| 12/20/2013 |
4
| Boothe Douglas (EVP & GM Perrigo Pharma) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Granted 1 shares
@ $0
Granted 395 restricted stock units
@ $0
Granted 1,336 restricted stock units
@ $0
Granted 2,473 options to buy
@ $104.47, valued at
$258.4k
Granted 6,245 options to buy
@ $119.78, valued at
$748k
|
|
| 12/19/2013 |
4
| Boothe Douglas (EVP & GM Perrigo Pharma) has filed a Form 4 on PERRIGO CO|
Txns:
| Disposed/sold 1 shares
@ $0
Disposed/sold 395 restricted stock units
@ $0
Disposed/sold 1,336 restricted stock units
@ $0
Disposed/sold 2,473 options to buy
@ $104.47, valued at
$258.4k
Disposed/sold 6,245 options to buy
@ $119.78, valued at
$748k
|
|
| 08/26/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/16/2013 |
4
| Boothe Douglas (EVP & GM Perrigo Pharma) has filed a Form 4 on PERRIGO CO|
Txns:
| Granted 2,473 options to buy
@ $104.47, valued at
$258.4k
Granted 395 restricted stock units
@ $0 |
|
| 01/16/2013 |
3
| Boothe Douglas (EVP & GM Perrigo Pharma) has filed a Form 3 on PERRIGO CO |
|
|